Profil
Gregory T.
Bates worked as Senior VP-Regulatory Affairs & Quality at XenoPort, Inc. He then worked as Vice President-Regulatory Affairs at ATAI Life Sciences NV from 2019 to 2022.
Bates received his undergraduate degree from the University of California, Berkeley and his doctorate degree from the University of California, Davis.
Anciens postes connus de Gregory T. Bates
| Sociétés | Poste | Fin |
|---|---|---|
| ATAI LIFE SCIENCES N.V. | Conseiller Juridique Général | 01/05/2022 |
| XENOPORT, INC. | Conseiller Juridique Général | - |
Formation de Gregory T. Bates
| University of California, Berkeley | Undergraduate Degree |
| University of California, Davis | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ATAI LIFE SCIENCES N.V. | Health Technology |
| Entreprise privées | 1 |
|---|---|
XenoPort, Inc.
 XenoPort, Inc. Pharmaceuticals: MajorHealth Technology XenoPort, Inc. operated as a biopharmaceutical company. Its products included horizant and regnite. The company was founded by Ronald W. Barrett, William J. Dower and Mark A. Gallop on December 17, 1999 and was headquartered in Atlanta, GA. | Health Technology |